BEVATAS 100MG

Product Description

BEVATAS 100 MG FAQ

1. What is Bevatas 100 mg?
Bevatas 100 mg is an anticancer injection containing Bevacizumab 100 mg in 4 mL.

2. What is the composition of Bevatas 100 mg?
Each 4 mL vial contains Bevacizumab 100 mg (25 mg/mL).

3. Who manufactures Bevatas 100 mg?
Bevatas is manufactured by Intas Pharmaceuticals Ltd.

4. How is Bevatas 100 mg administered?
It is administered as an intravenous (IV) infusion by a qualified healthcare professional. It should not be self-administered.

5. What cancers can Bevacizumab be used for?
Depending on the approved indication and treatment protocol, it may be used for colorectal, lung, kidney, ovarian, cervical and certain brain cancers.

6. How does Bevatas work?
It blocks VEGF, helping inhibit the formation of new blood vessels that can supply a tumor.

7. What are common side effects?
Possible side effects include high blood pressure, nosebleeds, protein in urine, headache, bleeding, weakness and infusion-related reactions.

8. Does Bevatas require refrigeration?
Yes. It should generally be stored at 28C and should not be frozen. Proper cold-chain handling is important.

9. Can Bevatas affect surgery or wound healing?
Yes. Bevacizumab can impair wound healing. The treating doctor should be informed before any surgery, and appropriate timing around major surgery is required.

10. Is Bevatas a prescription medicine?
Yes. It is a specialist oncology medicine and should be used only under the supervision and prescription of a qualified oncologist/healthcare professional.

11. Can Bevatas be used during pregnancy?
Bevacizumab can cause fetal harm and is generally contraindicated during pregnancy. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss this with their oncologist before treatment.

12. What is the pack size?
1 vial 4 mL, containing 100 mg Bevacizumab.

For patient-facing use, dosage, frequency, combination therapy and duration should always be presented as as prescribed by the treating oncologist, since these vary by cancer type and treatment protocol.